Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

James Basta

General Counsel at Intellia Therapeutics, Inc. (NTLA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $112K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 3SEC NTLAIntellia Therapeutics, Inc. Sell 1,211156,794 held (−1%) $13.78 $17K -17.1%
Jan 7SEC NTLAIntellia Therapeutics, Inc. Sell 10,397101,528 held (−9%) $9.21 $96K +24.0%